ArticleDiscover oncology2025
Combining machine learning and molecular docking to unravel the molecular network of bladder cancer induced by 2-naphthylamine.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectiveBladder cancer (BLCA) is among the most common malignant tumors found in the urinary tract. However, the carcinogenic mechanism of 2-Naphthylamine (2-NA), a class I carcinogen with a well-established association with BLCA, remains inadequately elucidated. The objective of research is to elucidate the molecular mechanisms underlying 2-NA-induced BLCA.
methodsAnalysis of differential expression was performed on various datasets to pinpoint target genes linked to BLCA. We used a comprehensive process integrating machine learning, network toxicology, molecular docking and molecular dynamics simulations to study the binding interactions between 2-NA and target proteins.
resultsOur research identified 29 potential targets implicated in 2-NA-induced BLCA. Subsequent analyses utilizing machine learning techniques prioritized 14 core genes (SKP2, SCN11A, DHCR7, AURKB, PFKFB4, EBP, CA2, NUDT1, DUSP2, KIF20A, BLM, IGFBP2, EZH2, TPX2) as pivotal regulators. SKP2 and EBP were identified as the most impactful predictors, showing notable effects in advancing bladder cancer. Furthermore, molecular docking simulations and molecular dynamics simulations indicated strong binding specificity between 2-NA and the target proteins SKP2 and EBP.
conclusionThe findings of our study indicate 2-NA potentially facilitates BLCA pathogenesis by influencing specific genes and signaling pathways. Utilizing machine learning techniques, 14 key genes were identified. Subsequent molecular docking analyses and molecular dynamics simulations verified the strong binding affinity of 2-NA to the critical targets SKP2 and EBP. These results provide valuable insights for further mechanistic investigations into 2-NA-induced bladder carcinogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.